AMLX Amylyx Pharmaceuticals Inc Total Business Assets
Amylyx Pharmaceuticals (AMLX) develops biopharmaceuticals in the field of neurology, where scaling depends on regulatory approvals and patents. The business is insulated from market cycles due to the critical importance of the therapy. This chart of the market trend for total assets in monetary terms reflects 229.57. However, Amylyx Pharmaceuticals (AMLX) is in a deep crisis: the recall of its primary ALS drug has shattered market confidence, necessitating a complete strategic pivot.
Analytical breakdowns and data insights for company Amylyx (AMLX)
- stock quotes and analyst forecast:
- market capitalization data:
- book capitalization information:
- debt burden and liquidity indicators:
All Debt to Shareholders' Equity Ratio Amylyx Pharmaceuticals|AMLX - Long-Term Debt to Equity|Current Liabilities to Capital Amylyx Corp|AMLX - Company Aggregate Debts|Debts to Book Capitalization Amylyx Corp|AMLX - Company Long-Term Debt|Company Current Liabilities Amylyx Pharmaceuticals|Immediate Liquidity amylyx.com
- company profitability and valuation multiples indicators:
Fundamental valuation:Amylyx Pharmaceuticals
Investors find it difficult to correlate current stock volatility with the actual scale of the business when risks overshadow short-term returns. An analysis of total assets, calculated inversely via ROA, allows for an assessment of the aggregate capital and resources of Amylyx Pharmaceuticals (AMLX), confirming the company's status as a defensive asset due to stable demand for innovative drugs regardless of macroeconomic cycles.
Main competitors
Total Business Assets BIIB|Aggregate Company Assets Neurocrine Biosciences, Inc.|Total Business Assets RGC (Regencell Bioscience Ltd)|Company Total Assets AXSM|ACAD - Company Assets|Xenon Pharmaceuticals - Cumulative Company Assets|Company Total Assets vikingtherapeutics.com VKTX|SUPN - Aggregate Company Assets|Aggregate Asset Value CPRX (Catalyst Pharma)|Denali Therapeutics Inc (DNLI) - Aggregate Company Assets|Company Assets Harmony Corp (HRMY)|BHVN (Biohaven Ltd.) - Company Total Assets|Company Total Assets trevitherapeutics.com|Aggregate Company Assets Praxis Precision Medicines, Inc. (PRAX)|Cumulative Company Assets Anavex AVXL|CeriBell Corp - Cumulative Company Assets|Prothena (PRTA) - Company Assets|ALEC - Aggregate Company Assets|ANNX: Aggregate Company Assets|OMER (omeros.com) - Cumulative Company Assets|Company Assets Neurogene Inc (NGNE)|Cumulative Company Assets ACIU|Total Business Assets VYGR (Voyager Corp)|Cumulative Company Assets NMRA (Neumora Therapeutics)|SCLX (scilexholding.com) - Aggregate Asset Value|Aggregate Company Assets Tevogen Bio TVGN|ACOG (Alpha Cognition Inc) - Total Asset Value of Company|Cognition Therapeutics, Inc. - Company Total Assets|Aggregate Asset Value IKT (Inhibikase Pharma)|SAVA: Company Total Assets|Assertio (ASRT) - Company Total Assets|Aggregate Company Assets Coya Therapeutics Inc|VTGN: Aggregate Asset Value|Aggregate Company Assets Ovid Therapeutics Inc. (OVID)|Cumulative Company Assets Acumen Pharmaceuticals, Inc ABOS|Company Total Assets CRVO (CervoMed Inc.)|Company Total Assets Alterity Therapeutics Ltd. ATHE|Clene Nanomedicine - Company Total Assets|PepGen Inc. (PEPG) - Cumulative Company Assets|JUNS: Company Total Assets|Company Assets Relmada Corp (RLMD)|Cumulative Company Assets ANVS|Company Total Assets Grace Tx|Cumulative Company Assets AIFF (Firefly Neuroscience)|Aggregate Business Assets KLTO|Company Total Assets NRSN (NeuroSense Therapeutics Ltd.)|Company Total Asset Base Reviva Pharmaceuticals, Inc. (RVPH)|MetaVia, Inc. - Company Total Assets|neuraxis.com (NRXS) - Cumulative Company Assets|HSDT: Company Total Assets|Passage Bio (PASG) - Company Total Assets|Aggregate Company Assets Neuphoria Therapeutics, Inc.|Aggregate Company Assets NERV|Aggregate Company Assets Athira Pharma, Inc. (ATHA)|Company Total Asset Base addextherapeutics.com|Company Total Assets ALZN (Alzamend Neuro)|Company Total Assets Cyclerion Therapeutics Inc. CYCN|PTIX - Aggregate Company Assets|Pasithea Therapeutics (KTTA) - Cumulative Company Assets|cortigent.com (CRGT) - Aggregate Company Assets|ATXI (avenuetx.com) - Aggregate Company Assets|Cumulative Company Assets BCLI|Total Business Assets CARA (Cara Therapeutics Inc.)|Aggregate Company Assets Chromocell Therapeutics Corporation (CHRO)|eliemtx.com - Total Business Assets|Company Total Assets ITCI (Intra-Cellular Therapies, Inc.)|longboardpharma.com (LBPH) - Company Assets|MRNS: Cumulative Company Assets|NKGN - Company Total Assets|NeuroBo (NRBO) - Aggregate Company Assets|Sage Therapeutics Inc - Aggregate Asset Value|Aggregate Company Assets Synaptogenix, Inc.|Company Assets trevena.com TRVN|Company Total Assets VIGL|Company Total Assets anewmeds.com (WENA)|Aggregate Company Assets Cerevel CERE